SCHEMBL984694

SCHEMBL984694

NC(=O)CCCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5736439 0.96 LMNA (0.44)
SCHEMBL8921255 0.96 KMT2A (0.46)
Bicarbonate SCHEMBL21296320 0.92 SLC22A6 (0.50)
Hydrochloric Acid SCHEMBL8373010 0.92 LMNA (0.41)
SCHEMBL125606 0.91 KMT2A (0.48)
SCHEMBL25288050 0.87 KMT2A (0.52)
SCHEMBL15007818 0.87 KMT2A (0.52)
SCHEMBL727151 0.87 KMT2A (0.52)
SCHEMBL25293609 0.87 KMT2A (0.52)
SCHEMBL699936 0.87 KMT2A (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 918 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600825-B2 Polymer compositions and biosurfaces comprising them on sensors ZEPTO LIFE TECHNOLOGY, INC. (US) 2026-04-14 US claimed
EP-4717733-A1 POLYAMIDE RESIN COMPOSITION UBE Corporation (JP) 2026-04-01 EP claimed
EP-4695324-A1 BIO-ORTHOGONAL HYDROGELS FOR SUSTAINED RELEASE DRUG DELIVERY Ocular Therapeutix, Inc. (US) 2026-02-18 EP claimed
EP-3725771-B1 ALK PROTEIN DEGRADATION AGENT AND ANTI-TUMOR APPLICATION THEREOF UNIV SHANGHAI TECHNOLOGY (CN) 2026-02-04 EP claimed
EP-4683964-A2 POLY(ETHYLENE GLYCOL) BASED DENDRIMER-LIKE HYPERBRANCHED MACROMOLECULES, METHODS OF PREPARATION AND USE THEREOF Ocular Therapeutix, Inc. (US) 2026-01-28 EP claimed
EP-4605387-A1 MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE Arvinas Operations, Inc. (US) 2025-08-27 EP claimed
EP-3762381-B1 BIVALENT AGENTS COMPRISING A SERINE THREONINE KINASE (AKT) LIGAND COVALENTLY LINKED TO A DEGRADATION/DISRUPTION MOIETY FOR THE TREATMENT OF CANCER ICAHN SCHOOL MED MOUNT SINAI (US) 2025-05-07 EP claimed
CN-119798688-A Preparation method and application of iron doped polymer self-assembled nano particles 中国科学院大连化学物理研究所 2025-04-11 CN claimed
CN-119799319-A Phosphorescent material and preparation method thereof 中国科学院大连化学物理研究所 2025-04-11 CN claimed
US-20250084031-A1 METHOD OF PREPARING GLUCOSE-DERIVED ADIPONITRILE AND A METHOD OF DEHYDRATING BIOMASS-DERIVED AMIDE COMPOUND HYUNDAI MOTOR COMPANY (KR) 2025-03-13 US claimed
WO-1997037689-A2 DENATURANTS FOR SYMPATHOMIMETIC AMINE SALTS WARNER-LAMBERT COMPANY (US) 1997-10-16 WO claimed
EP-0469919-B1 A process for the enzymatic preparation of 7-aminocephalosporanic acid ANTIBIOTICOS SPA (IT) 1997-04-09 EP claimed
EP-0392317-B1 Benzimidazoles, drugs containing these compounds and process for their preparation THOMAE GMBH DR K (DE) 1996-01-03 EP claimed
US-5459147-A Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma DR. KARL THOMAE GMBH (DE) 1995-10-17 US claimed
US-5354667-A Use of recombinant DNA techniques ANTIBIOTICOS, S.P.A. (IT) 1994-10-11 US claimed
US-5270206-A Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents PFIZER INC. (US) 1993-12-14 US claimed
EP-0469919-A2 A process for the enzymatic preparation of 7-aminocephalosporanic acid ANTIBIOTICOS, S.p.A. (IT) 1992-02-05 EP claimed
EP-0454444-A1 Glutarimide derivatives and herbicides NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1991-10-30 EP claimed
EP-0319644-A2 Alkylated amide derivatives, their use and pharmaceutical compositions containing them THE GREEN CROSS CORPORATION (JP) 1989-06-14 EP claimed
US-4227882-A DISCOLORATION INHIBITION BY TREATMENT WITH AN AMINOALKYLCARBOXY ACID OR SALT KANEBO, LTD. (JP) 1980-10-14 US claimed